A child with atypical hemolytic uremic syndrome: Is there a rationale to stop eculizumab?

TK Levart - Clinical Nephrology, 2020 - search.proquest.com
Discussion Eculizumab is an excellent drug for treating aHUS, with an overall favorable risk
profile [1, 2]. However, several issues remain to be addressed with respect to life-long …
被引用次数：1 相关文章

[引用][C] A child with atypical hemolytic uremic syndrome: Is there a rationale to stop eculizumab?

Clinical Nephrology, 2020 - europepmc.org
A child with atypical hemolytic uremic syndrome: Is there a rationale to stop eculizumab? -
Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About …

[引用][C] A child with atypical hemolytic uremic syndrome: Is there a rationale to stop eculizumab?

TK Levart - Clinical nephrology, 2020 - pubmed.ncbi.nlm.nih.gov